A meta-analysis of 13 smaller studies in overweight or obese T1Ds produced similar findings, strengthening the case for broader research
Type 2 Diabetes: Blood Sugar Control: Semaglutide helps lower blood sugar levels by increasing insulin secretion and reducing glucagon release, which leads to improved glycemic control
It's estimated that they affect up to 25% of people who menstruate
References Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ
The theoretical concern with BPC-157 follows a similar pattern: biological plausibility exists, but demonstrable risk has not materialized